Peptide record

TPDB07282

Antibacterial Antifungal Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07282
Antibacterial Antifungal Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept
standard
No
A 13-aa standard natural multi-activity (Antibacterial, Antifungal, and Toxicity) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
ILKWKWPWWPWRR
Physicochemical Analysis
C101H136N26O14
ANDCEQGHMFSTYV
W
1938.36
12.42
4
0
7
+4
-5.62
-1.246
60.00
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
27500
1418.73
0
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
1
L
2
K
0
M
0
F
2
P
0
S
0
T
5
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 1 K: 2 M: 0 F: 0 P: 2 S: 0 T: 0 W: 5 Y: 0 V: 0
Chemical Descriptors
13
C101H136N26O14
1938.36
12.42
+4
-5.62
-1.246
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
16 µg/mL

Target

Pseudomonas aeruginosa PAO1

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against P. aeruginosa PAO1 (MIC 16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epider
Evidence 2 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

active against P. aeruginosa PAO1 (MIC 16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E.
Evidence 3 Activity

Activity

MIC
Antibacterial
31 µg/mL

Target

S. typhimurium

Source & Reference

dbAMP DRAMP

Other

active against P. aeruginosa PAO1 (MIC 16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/
Evidence 4 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

P. aeruginosa PAO1 (MIC 16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/ml), and C. albicans (MIC
Evidence 5 Activity

Activity

MIC
Antibacterial
4 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP

Other

16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/ml), and C. albicans (MIC 8 ug/ml).
Evidence 6 Activity

Activity

MIC
Antibacterial
31 µg/mL

Target

Enterococcus faecalis ATCC29212

Source & Reference

dbAMP DRAMP

Other

l), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/ml), and C. albicans (MIC 8 ug/ml).
Evidence 7 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

us (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/ml), and C. albicans (MIC 8 ug/ml).
Evidence 8 Activity

Activity

MIC
Antifungal
16 µg/mL

Target

Pseudomonas aeruginosa PAO1

Source & Reference

dbAMP DRAMP Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against P. aeruginosa PAO1 (MIC 16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epider
Evidence 9 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP Antifungipept

Other

active against P. aeruginosa PAO1 (MIC 16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E.
Evidence 10 Activity

Activity

MIC
Antifungal
31 µg/mL

Target

S. typhimurium

Source & Reference

dbAMP DRAMP Antifungipept

Other

active against P. aeruginosa PAO1 (MIC 16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/
Evidence 11 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP Antifungipept

Other

P. aeruginosa PAO1 (MIC 16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/ml), and C. albicans (MIC
Evidence 12 Activity

Activity

MIC
Antifungal
4 µg/mL

Target

Staphylococcus epidermidis

Source & Reference

dbAMP DRAMP Antifungipept

Other

16 ug/ml), E. coli (MIC 8 ug/ml), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/ml), and C. albicans (MIC 8 ug/ml).
Evidence 13 Activity

Activity

MIC
Antifungal
31 µg/mL

Target

Enterococcus faecalis ATCC29212

Source & Reference

dbAMP DRAMP Antifungipept

Other

l), S. typhimurium (MIC 31 ug/ml), S. aureus (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/ml), and C. albicans (MIC 8 ug/ml).
Evidence 14 Activity

Activity

MIC
Antifungal
8 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP Antifungipept

Other

us (MIC 8 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 31 ug/ml), and C. albicans (MIC 8 ug/ml).
Evidence 15 Activity

Activity

50% Hemolysis
Toxicity
400 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 400 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity | Peptides | 2009
Evidence 16 Activity

Activity

HC50
Toxicity
400 µg/mL
Hemolytic
Hemolytic_activity: [Ref.19428758] HC50=400 µg/ml against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
Peptides. 2009 May 30(5):832-8. doi: 10.1016/j.peptides.2009.01.015.